Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03787212 · ClinicalTrials.gov registry record · NA
MiBo ThermoFlo Lid Temperature Evaluation
A NA study, sponsored by Johnson & Johnson Vision Care.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03787212 is a NA study that was terminated before completion, run by Johnson & Johnson Vision Care. The registered enrollment target is 4 participants.
The verdict
NCT03787212, a NA study, was terminated before completion, sponsored by Johnson & Johnson Vision Care.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study is a prospective, contralateral, single-site, single-visit unmasked evaluation of external and internal eyelid temperature after treatment with the MiBo ThermoFlo.
Interventions
- DEVICE MiBo ThermoFlo
- DEVICE Bruder Mask
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-12-06 |
| Est. Completion | 2019-01-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03787212
The ClinicalTrials.gov registry entry for NCT03787212 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MiBo ThermoFlo is the first listed.
NCT03787212 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03787212 about?
NCT03787212 is a clinical study titled "MiBo ThermoFlo Lid Temperature Evaluation". This study is a prospective, contralateral, single-site, single-visit unmasked evaluation of external and internal eyelid temperature after treatment with the MiBo ThermoFlo.
What is the current status of trial NCT03787212?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2018-12-06. Estimated completion is 2019-01-28.
What interventions are being tested in trial NCT03787212?
The interventions under investigation include: MiBo ThermoFlo (DEVICE), Bruder Mask (DEVICE).
Who is sponsoring clinical trial NCT03787212?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.